Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US61/518,916 priority Critical Priority to US201161518921P priority Priority to US201161518903P priority Priority to US201161518916P priority Priority to US201161518913P priority Priority to US61/518,903 priority Priority to US61/518,913 priority Priority to US61/518,921 priority Priority to US61/486,252 priority Priority to US201161486252P priority Priority to US201161486251P priority Priority to US201161486254P priority Priority to US201161486266P priority Priority to US61/486,251 priority Priority to US61/486,254 priority Priority to US61/486,266 priority Priority to US61/513,495 priority Priority to US61/513,497 priority Priority to US201161513497P priority Priority to US201161513499P priority Priority to US61/513,499 priority Priority to US201161513495P priority Priority to US61/598,336 priority Priority to US201261598336P priority Priority to US201261598329P priority Priority to US201261598333P priority Priority to US201261598335P priority Priority to US61/598,329 priority Priority to US61/598,333 priority Priority to US61/598,335 priority Application filed by Trimel Pharmaceuticals Corp. Testosterone supplementation is used by some healthcare providers to help with such bodily issues. This drop in testosterone has been hypothesized to lead to various things, such as decreased sexual function, anemia, and bone breaks. Priority date (The priority date is an assumption and is not a legal conclusion. As men get older, the levels of testosterone in their blood often drop. Inventor Wayne KREPPNER Siobhan Fogarty Werner Oberegger Paul José Pierre Marie MAES Original Assignee Trimel Pharmaceuticals Corp.
Phlo gel ultra testosterone homebrew pdf#
Google Patents Formulations de gel de testostérone faiblement dosées à usage intranasal et leur utilisation pour traiter l'anorgasmie ou la baisse du désir sexuelĭownload PDF Info Publication number WO2012156821A1 WO2012156821A1 PCT/IB2012/001113 IB2012001113W WO2012156821A1 WO 2012156821 A1 WO2012156821 A1 WO 2012156821A1 IB 2012001113 W IB2012001113 W IB 2012001113W WO 2012156821 A1 WO2012156821 A1 WO 2012156821A1 Authority WO WIPO (PCT) Prior art keywords testosterone gel formulation subject formulation nasal administration Prior art date Application number PCT/IB2012/001113 Other languages English ( en) Google Patents WO2012156821A1 - Formulations de gel de testostérone faiblement dosées à usage intranasal et leur utilisation pour traiter l'anorgasmie ou la baisse du désir sexuel WO2012156821A1 - Formulations de gel de testostérone faiblement dosées à usage intranasal et leur utilisation pour traiter l'anorgasmie ou la baisse du désir sexuel
0 kommentar(er)
